| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors
|
Sandhu, Shahneen K.
|
|
2013
|
71 |
4 |
p. 1041-1050
|
artikel
|
| 2 |
All-oral combination of vinorelbine and capecitabine as first-line treatment in HER2/Neu-negative metastatic breast cancer
|
Tawfik, Hesham
|
|
2013
|
71 |
4 |
p. 913-919
|
artikel
|
| 3 |
A mathematical model for the administration of temozolomide: comparative analysis of conventional and metronomic chemotherapy regimens
|
Faivre, C.
|
|
2013
|
71 |
4 |
p. 1013-1019
|
artikel
|
| 4 |
A multi-histology trial of fostamatinib in patients with advanced colorectal, non-small cell lung, head and neck, thyroid, and renal cell carcinomas, and pheochromocytomas
|
Park, Sook Ryun
|
|
2013
|
71 |
4 |
p. 981-990
|
artikel
|
| 5 |
An integrin-targeted, pan-isoform, phosphoinositide-3 kinase inhibitor, SF1126, has activity against multiple myeloma in vivo
|
De, Pradip
|
|
2013
|
71 |
4 |
p. 867-881
|
artikel
|
| 6 |
Anti-tumour and anti-vascular effects of cediranib (AZD2171) alone and in combination with other anti-tumour therapies
|
Kendrew, Jane
|
|
2013
|
71 |
4 |
p. 1021-1032
|
artikel
|
| 7 |
A phase II study of oxaliplatin in combination with leucovorin and fluorouracil as first-line chemotherapy in patients with metastatic squamous cell carcinoma of esophagus
|
Wang, Jialei
|
|
2013
|
71 |
4 |
p. 905-911
|
artikel
|
| 8 |
A phase I study of hepatic arterial infusion of nab-paclitaxel in combination with intravenous gemcitabine and bevacizumab for patients with advanced cancers and predominant liver metastases
|
Tsimberidou, Apostolia M.
|
|
2013
|
71 |
4 |
p. 955-963
|
artikel
|
| 9 |
A phase I study of tasisulam sodium using an albumin-tailored dose in Japanese patients with advanced solid tumors
|
Fujiwara, Yutaka
|
|
2013
|
71 |
4 |
p. 991-998
|
artikel
|
| 10 |
A phase 2 study of KX2-391, an oral inhibitor of Src kinase and tubulin polymerization, in men with bone-metastatic castration-resistant prostate cancer
|
Antonarakis, Emmanuel S.
|
|
2013
|
71 |
4 |
p. 883-892
|
artikel
|
| 11 |
A randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine monotherapy for advanced biliary tract cancer
|
Sasaki, Takashi
|
|
2013
|
71 |
4 |
p. 973-979
|
artikel
|
| 12 |
Clusterin inhibition to enhance tumor chemosensitivity in systemic tumors
|
Kapoor, Shailendra
|
|
2013
|
71 |
4 |
p. 1101
|
artikel
|
| 13 |
Combination of gemcitabine and carboplatin as first line treatment in elderly patients or those unfit for cisplatin-based chemotherapy with advanced transitional cell carcinoma of the urinary tract
|
Park, Joo Hee
|
|
2013
|
71 |
4 |
p. 1033-1039
|
artikel
|
| 14 |
Correlation between expressions of ERCC1/TS mRNA and effects of gastric cancer to chemotherapy in the short term
|
Chen, Liqi
|
|
2013
|
71 |
4 |
p. 921-928
|
artikel
|
| 15 |
Effect of TP53 codon 72 and MDM2 SNP309 polymorphisms on survival of gastric cancer among patients who receiving 5-fluorouracil-based postoperative adjuvant chemotherapy
|
Wang, Shizhi
|
|
2013
|
71 |
4 |
p. 1073-1082
|
artikel
|
| 16 |
Erratum to: Pharmacokinetic–pharmacodynamic relationship of bosutinib in patients with chronic-phase chronic myeloid leukemia
|
Hsyu, Poe-Hirr
|
|
2013
|
71 |
4 |
p. 1105-1106
|
artikel
|
| 17 |
Genetic basis for the increased expression of vacuolar H+ translocating ATPase genes upon imatinib treatment in human lymphoblastoid cells
|
Kulkarni, Hemant
|
|
2013
|
71 |
4 |
p. 1095-1100
|
artikel
|
| 18 |
Multicenter phase II study of S-1 and docetaxel combination chemotherapy for advanced or recurrent gastric cancer patients with peritoneal dissemination
|
Shigeyasu, Kunitoshi
|
|
2013
|
71 |
4 |
p. 937-943
|
artikel
|
| 19 |
Multicenter phase II trial of preoperative chemoradiotherapy with S-1 for locally advanced oral squamous cell carcinoma
|
Harada, Hiroyuki
|
|
2013
|
71 |
4 |
p. 1059-1064
|
artikel
|
| 20 |
Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway
|
Burris, Howard A.
|
|
2013
|
71 |
4 |
p. 829-842
|
artikel
|
| 21 |
Pharmacodynamic stimulation of thrombogenesis by angiotensin (1–7) in recurrent ovarian cancer patients receiving gemcitabine and platinum-based chemotherapy
|
Pham, Huyen
|
|
2013
|
71 |
4 |
p. 965-972
|
artikel
|
| 22 |
Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer
|
Lee, Kyung-Hun
|
|
2013
|
71 |
4 |
p. 843-851
|
artikel
|
| 23 |
Phase I and pharmacokinetic study of gefitinib and S-1 combination therapy for advanced adenocarcinoma of the lung
|
Kiyota, Hidemi
|
|
2013
|
71 |
4 |
p. 859-865
|
artikel
|
| 24 |
Phase I dose-escalation study of docetaxel, nedaplatin, and 5-fluorouracil combination chemotherapy in patients with advanced esophageal cancer
|
Miyazaki, Tatsuya
|
|
2013
|
71 |
4 |
p. 853-857
|
artikel
|
| 25 |
Phase I/II study of albumin-bound nab-paclitaxel plus gemcitabine administered to Chinese patients with advanced pancreatic cancer
|
Zhang, Dong-sheng
|
|
|
71 |
4 |
p. 1065-1072
|
artikel
|
| 26 |
Phase I/II study of albumin-bound nab-paclitaxel plus gemcitabine administered to Chinese patients with advanced pancreatic cancer
|
Zhang, Dong-sheng
|
|
2013
|
71 |
4 |
p. 1065-1072
|
artikel
|
| 27 |
Phase I study to assess the pharmacokinetics and the effect on cardiac repolarization of amrubicin and amrubicinol in patients with advanced solid tumors
|
Chen, Nianhang
|
|
2013
|
71 |
4 |
p. 1083-1094
|
artikel
|
| 28 |
Repeated radioimmunotherapy with 131I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphoma
|
Kang, Hye Jin
|
|
2013
|
71 |
4 |
p. 945-953
|
artikel
|
| 29 |
Reply to: Clusterin inhibition to enhance tumor chemosensitivity in systemic tumors
|
Cheng, Ching-Yuan
|
|
2013
|
71 |
4 |
p. 1103-1104
|
artikel
|
| 30 |
The Breast Avastin Trial: phase II study of bevacizumab maintenance therapy after induction chemotherapy with docetaxel and capecitabine for the first-line treatment of patients with locally recurrent or metastatic breast cancer
|
Bisagni, G.
|
|
2013
|
71 |
4 |
p. 1051-1057
|
artikel
|
| 31 |
The PPARγ agonist pioglitazone crosses the blood–brain barrier and reduces tumor growth in a human xenograft model
|
Grommes, Christian
|
|
2013
|
71 |
4 |
p. 929-936
|
artikel
|
| 32 |
Therapeutic targeting malignant mesothelioma with a novel 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate via its selective uptake by the proton-coupled folate transporter
|
Cherian, Christina
|
|
2013
|
71 |
4 |
p. 999-1011
|
artikel
|
| 33 |
Thrombocytosis and immunohistochemical expression of connexin 43 at diagnosis predict survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy
|
Du, Gangjun
|
|
2013
|
71 |
4 |
p. 893-904
|
artikel
|
Tijdschrift beschrijving